Physician Payments Sunshine Provisions in Health Care Reform
The Physician Payments Sunshine provisions in health care reform legislation require drug and medical device manufacturers to publicly report gifts and payments made to physicians and teaching hospitals. The Physician Payment Sunshine provisions were included in the Patient Protection and Affordable Care Act of 2009 (H.R. 3590, section 6002) which was signed into law on March 23, 2010. This fact sheet from the Pew Prescription Project describes the policies enacted and answers common questions about the new regulation.
Download the full PDF for more information.
This visualization highlights key recommendations by an expert task force of leaders from academic medical centers, patient health advocates and physician organizations in identifying best practices for conflict-of-interest policies at academic medical centers. More info
The federal government’s Centers for Medicare & Medicaid Services yesterday began allowing pharmaceutical and medical device companies to register online for the new “Open Payments” website, authorized under the Physician Payments Sunshine Act to make more transparent the disclosure of financial interactions among physicians. More info
A closer look at task force recommendations from the Conflict-of-Interest Policies for Academic Medical Centers as they relate to the relationships between the institutions and industry. More info
In 2012, The Pew Charitable Trusts convened an expert task force on conflicts of interest in medicine to assist academic medical centers in identifying best practices to incorporate into their conflict-of-interest policies. The task force formulated recommendations in 15 areas in order to protect the integrity of education and training and the practice of medicine within the academic medical center while not standing as an impediment to research and scientific inquiry. More info
In 2011, the pharmaceutical industry spent nearly $29 billion on drug promotion — more than $25 billion on marketing directly to physicians and almost $4 billion on advertising directly to consumers (mainly through television commercials). This multi-pronged approach is designed to promote its products by influencing doctors’ prescribing practices.